<
new post
StocksRunner logo
mail
search
 
menu
 
Sanofi
$47.71
+1.06%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

SNY Stock Analysis & IQ Rating | Sanofi

 
 

SNY

 

Sanofi

$47.71

 
+$0.49 | +1.06%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$60.12
 
 
MKT CAP
$117.31B
 
52W Low
$44.62
 
 
VOL
$2.33M
 
P/E Ratio
20.09
 
 
AVG VOL
$4.50M
 
RSI
51.91
 
 
TREND
Sideways
 
 
 

SNY Stock IQ

 
lock  Login to see Sanofi (SNY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

SNY Target Price

 
 
 

Strengths

 
 

SNY Rewards

 Earnings are forecast to grow

SNY Rewards

 Trading below its fair value

SNY Rewards

 Upgraded on attractively valued

SNY Rewards

 Expands stock buyback program

 
 

SNY Price Performance

 
 

$47.49   (+0.46%)

$50.03   (-4.64%)

$47.2   (+1.08%)

$58.74   (-18.78%)

 
 
1year
6month
3month
1month

SNY Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

SNY Earnings Sentiment Above analyst estimates
SNY Earnings Sentiment Reported a weak earnings

Rating

×

Rating

SNY Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

SNY Activity Sentiment Expands stock buyback program

Future

×

Future

SNY Future Sentiment Earnings are forecast to grow
SNY Future Sentiment Trading below its fair value
SNY Analysts Opinion

SNY Analysts opinion is positive but there was a setback from the past 3 months

SNY Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

85%
Consensus Rating
0%
Buy
Opinion
40%
Trend
Score
100%
Potential
Score
SNY Street Sentiment

SNY Street Sentiment is extremely bullish and have positive views on the near-term outlook

SNY Risk Level

SNY has Low risk level

Risk Indicators

Hit 52-week low
SNY Risk Level
Low
LOW
HIGH

SNY Performance Sentiment

Sentiments overview associated with events and the stock performance

85%
Positive
58 out of 68
events present
13%
Negative
9 out of 68
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$45.77
Resistance Price
$49.25
Current Price Range
$47.22
$45.77
$49.25
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
50%
Consensus Rating
NEUTRAL
3
Buy
2
Hold
1
Sell
Date
Action
Rating
Firm

Feb 12, 2026

 

Downgrade

 

Neutral

 

BofA

 

Jan 26, 2026

 

Downgrade

 

Neutral

 

UBS

 

Jan 12, 2026

 

Downgrade

 

Equal

 

Barclays

 

Dec 30, 2025

 

Reiterate

 

its Buy

 

Jefferies

 

Dec 16, 2025

 

Reiterate

 

Buy

 

INTESA SANPAOLO EQUITY RESEARCH

 
 
 
SNY Latest Analysis +
 
 
FAQ About SNY Stock Insights
 

What is SNY current stock price?

What are SNY stock strengths?

What is SNY Risk Level?

What is SNY market cap and volume?

What is SNY current Stock IQ?

Should I buy SNY stock right now?

Is SNY a Strong Buy right now?

What does a 'Strong Buy' rating mean for SNY?

What does a 'Strong Sell' rating mean for SNY?

What factors influence SNY's Stock IQ?

 
 
StocksRunner

Explore our SNY Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored SNY Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our SNY Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

SNY

 

Sanofi

 
Set Alerts
 
 

Current Price

 

$47.71

 
+$0.49 | +1.06%
 
 
52W High
$60.12
 
 
MKT CAP
$117.31B
 
52W Low
$44.62
 
 
VOL
$2.33M
 
P/E Ratio
20.09
 
 
AVG VOL
$4.50M
 
RSI
51.91
 
 
TREND
Sideways
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 
user
 
 
 
 

SNY Price Performance

 
 

$47.49   (+0.46%)

$50.03   (-4.64%)

$47.2   (+1.08%)

$58.74   (-18.78%)

 
 
1year
6month
3month
1month
 

SNY Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

SNY Earnings Sentiment Above analyst estimates
SNY Earnings Sentiment Reported a weak earnings

Rating

×

Rating

SNY Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

SNY Activity Sentiment Expands stock buyback program

Future

×

Future

SNY Future Sentiment Earnings are forecast to grow
SNY Future Sentiment Trading below its fair value
SNY Analysts Opinion

SNY Analysts opinion is positive but there was a setback from the past 3 months

SNY Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

85%
Consensus Rating
0%
Buy
Opinion
40%
Trend
Score
100%
Potential
Score
SNY Street Sentiment

SNY Street Sentiment is extremely bullish and have positive views on the near-term outlook

SNY Risk Level

SNY has Low risk level

Risk Indicators

Hit 52-week low
SNY Risk Level
Low
LOW
HIGH
SNY Performance Sentiment
Sentiments overview associated with events and the stock performance.
85%
Positive
58 out of 68
events present
13%
Negative
9 out of 68
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$45.77
Resistance Price
$49.25
Current Price Range
$47.22
$45.77
$49.25
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

50%
Consensus Rating
NEUTRAL
3
Buy
2
Hold
1
Sell
Date
Action
Rating
Firm
Feb 12, 2026
Downgrade
Neutral
BofA
Jan 26, 2026
Downgrade
Neutral
UBS
Jan 12, 2026
Downgrade
Equal
Barclays
Dec 30, 2025
Reiterate
its Buy
Jefferies
Dec 16, 2025
Reiterate
Buy
INTESA SANPAOLO EQUITY RESEARCH
Dec 16, 2025
Reiterate
Buy
Jefferies
Dec 16, 2025
Reiterate
Buy
ODDO BHF
Dec 16, 2025
Reiterate
Sell
DAY BY DAY
 
 
 
 

SNY Stock IQ

 
 
 
lock  Login to unlock Sanofi (SNY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

SNY Rewards

 Earnings are forecast to grow

SNY Rewards

 Trading below its fair value

SNY Rewards

 Upgraded on attractively valued

SNY Rewards

 Expands stock buyback program

 
 
 

SNY Latest Analysis

 
 
 

Sanofis (SNY) R&D Track Record Remains Investor Concern Says BofA. Sanofi (NASDAQ:SNY) is among the 7 Oversold Pharma Stocks to Buy Now. Sanofi (NASDAQ:SNY) is one of the most oversold stocks. TheFly reported that on February 20 SNYs price target was lowered at Citi by EUR 5. On the other hand earlier on February 12 BofA reduced its price target for SNY from EUR 102 [….]

 

Mon Feb 23, 2026

$47.22 | +0.98%
 
Activity
Potential

Manuela Buxo To Become Head of Sanofis (SNY) Specialty Care Global Business Unit. Sanofi (NASDAQ:SNY) is one of the Best Dip Stocks to Buy According to Hedge Funds. On February 17 Sanofi (NASDAQ:SNY) announced Manuela Buxo will replace Brian Foard as the Head of its Specialty Care Global Business Unit. Brian Foard after serving for nearly 9 years is leaving on February 28 to take on a leadership [….]

 

Fri Feb 20, 2026

$46.76 | -1.31%
 
Potential

Sanofi sued by Texas AG for running kickback scheme for doctors.

 

Fri Feb 20, 2026

$46.76 | -1.31%
 
Activity

Teva Sanofis Phase 2b Trial Of Duvakitug Shows Durable Efficacy In UC & Crohns . (RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) and Sanofi (SNY) will hold an investor call and webcast today to highlight new Phase 2b maintenance data for Duvakitug. The investigational therapy demonstrated clinically meaningful and durable efficacy in patients with ulce

 

Tue Feb 17, 2026

$46.43 | +0.91%
 
Activity

Sanofi Experimental Drug Helps Patients With Bowel Disease. Sanofi said an experimental medicine its developing with Teva Pharmaceuticals Inc. helped patients with inflammatory bowel disease.

 

Tue Feb 17, 2026

$46.43 | +0.91%
 
Activity

Teva and Sanofis duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohns disease. PARSIPPANY N.J. and PARIS Feb. 17 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals a United States affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Sanofi announced positive results from the RELIEVE UCCD long-term extension (LTE) study of duvakitug an investigational human monoclonal antibody targeting TL1A which showed durable

 

Tue Feb 17, 2026

$46.43 | +0.91%
 
Activity

Press Release: Sanofi and Tevas duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohns disease. Sanofi and Teva'.s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn'.s diseaseParis and Parsippany NJ February 17 2026. Positive results from the RELIEVE UCCD long-term extension (LTE) study (clinical study identifier: ) of duvakitug an investigational human

 

Tue Feb 17, 2026

$46.43 | +0.91%
 
Activity
 
 
 
 
 
StocksRunner

Discover SNY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of SNY. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our SNY Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

SNY Stock trends

SNY Stock performance

SNY Stock analysis

SNY investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

SNY Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing SNY

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing SNY

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.